Search

Your search keyword '"Cercek, A."' showing total 2,257 results
Start Over Author "Cercek, A."
2,257 results on '"Cercek, A."'

102. Impact of Routine Invasive Physiology at Time of Angiography in Patients With Multivessel Coronary Artery Disease on Reclassification of Revascularization Strategy: Results From the DEFINE REAL Study

Author

Van Belle, Eric, Gil, Robert, Klauss, Volker, Balghith, Mohammed, Meuwissen, Martijn, Clerc, Jérôme, Witzenbichler, Bernhard, Cercek, Miha, Vlachojannis, Marios, Lang, Irene, Commeau, Philippe, Vincent, Flavien, Testa, Luca, Wasek, Wojciech, Debry, Nicolas, Kische, Stephan, Gabrielli, Gabriele, and Sardella, Gennaro

Published
2018
Full Text
View/download PDF

103. Electron dynamics at the initial stage of floating-sheath formation

Author

Lupu, Catalin, Tskhakaya, Davy D., Kuhn, Siegbert, Cercek, Milan, Schrittwieser, Roman, and Popa, Cheorghe

Subjects
Physics - Plasma Physics
Abstract

The problem of sheath formation in front of a conductive planar plate inserted into the plasma is formulated. Initially, the plate is assumed to be neutral. It is shown that the charging-up process of the plate is accompanied by the excitation of electron plasma waves., Comment: 12th International Congress on Plasma Physics, 25-29 October 2004, Nice (France)

Published
2004

104. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: insights from the ISACS STEMI COVID 19 Registry

Author

De Luca, Giuseppe, Cercek, Miha, Jensen, Lisette Okkels, Vavlukis, Marija, Calmac, Lucian, Johnson, Tom, Roura i Ferrer, Gerard, Ganyukov, Vladimir, Wojakowski, Wojtek, von Birgelen, Clemens, Versaci, Francesco, Ten Berg, Jurrien, Laine, Mika, Dirksen, Maurits, Casella, Gianni, Kala, Petr, Díez Gil, José Luis, Becerra, Victor, De Simone, Ciro, Carrill, Xavier, Scoccia, Alessandra, Lux, Arpad, Kovarnik, Tomas, Davlouros, Periklis, Gabrielli, Gabriele, Flores Rios, Xacobe, Bakraceski, Nikola, Levesque, Sébastien, Guiducci, Vincenzo, Kidawa, Michał, Marinucci, Lucia, Zilio, Filippo, Galasso, Gennaro, Fabris, Enrico, Menichelli, Maurizio, Manzo, Stephane, Caiazzo, Gianluca, Moreu, Jose, Sanchis Forés, Juan, Donazzan, Luca, Vignali, Luigi, Teles, Rui, Bosa Ojeda, Francisco, Lehtola, Heidi, Camacho-Freiere, Santiago, Kraaijeveld, Adriaan, Antti, Ylitalo, Boccalatte, Marco, Martínez-Luengas, Iñigo Lozano, Scheller, Bruno, Alexopoulos, Dimitrios, Uccello, Giuseppe, Faurie, Benjamin, Gutierrez Barrios, Alejandro, Wilbert, Bor, Cortese, Giuliana, Moreno, Raul, Parodi, Guido, Kedhi, Elvin, and Verdoia, Monica

Published
2020
Full Text
View/download PDF

105. The Role of T Cells Reactive to the Cathelicidin Antimicrobial Peptide LL-37 in Acute Coronary Syndrome and Plaque Calcification

Author

Fernando Chernomordik, Bojan Cercek, Wai Man Lio, Peter M. Mihailovic, Juliana Yano, Romana Herscovici, Xiaoning Zhao, Jianchang Zhou, Kuang-Yuh Chyu, Prediman K. Shah, and Paul C. Dimayuga

Subjects
acute coronary syndrome, T cells, atherosclerosis, cathelicidin, LL-37, mCRAMP, Immunologic diseases. Allergy, RC581-607
Abstract

The human cationic anti-microbial peptide LL-37 is a T cell self-antigen in patients with psoriasis, who have increased risk of cardiovascular events. However, the role of LL-37 as a T cell self-antigen in the context of atherosclerosis remains unclear. The objective of this study was to test for the presence of T cells reactive to LL-37 in patients with acute coronary syndrome (ACS). Furthermore, the role of T cells reactive to LL-37 in atherosclerosis was assessed using apoE−/− mice immunized with the LL-37 mouse ortholog, mCRAMP. Peripheral blood mononuclear cells (PBMCs) from patients with ACS were stimulated with LL-37. PBMCs from stable coronary artery disease (CAD) patients or self-reported subjects served as controls. T cell memory responses were analyzed with flow cytometry. Stimulation of PBMCs with LL-37 reduced CD8+ effector T cell responses in controls and patients with stable CAD but not in ACS and was associated with reduced programmed cell death protein 1 (PDCD1) mRNA expression. For the mouse studies, donor apoE−/− mice were immunized with mCRAMP or adjuvant as controls, then T cells were isolated and adoptively transferred into recipient apoE−/− mice fed a Western diet. Recipient mice were euthanized after 5 weeks. Whole aortas and hearts were collected for analysis of atherosclerotic plaques. Spleens were collected for flow cytometric and mRNA expression analysis. Adoptive transfer experiments in apoE−/− mice showed a 28% reduction in aortic plaque area in mCRAMP T cell recipient mice (P < 0.05). Fifty six percent of adjuvant T cell recipient mice showed calcification in atherosclerotic plaques, compared to none in the mCRAMP T cell recipient mice (Fisher’s exact test P = 0.003). Recipients of T cells from mice immunized with mCRAMP had increased IL-10 and IFN-γ expression in CD8+ T cells compared to controls. In conclusion, the persistence of CD8+ effector T cell response in PBMCs from patients with ACS stimulated with LL-37 suggests that LL-37-reactive T cells may be involved in the acute event. Furthermore, studies in apoE−/− mice suggest that T cells reactive to mCRAMP are functionally active in atherosclerosis and may be involved in modulating plaque calcification.

Published
2020
Full Text
View/download PDF

106. The impact of germline alterations in appendiceal adenocarcinoma

Author

Michael B. Foote, Henry Walch, Yelena Kemel, Efsevia Vakiani, Paul Johannet, Margaret Sheehan, Walid Chatila, Sebastian Chung, Garrett NASH, Anna Maio, Jinru Shia, Diana Mandelker, Michael Berger, Nikolaus Schultz, Luis A. Diaz, Andrea Cercek, and Zsofia K. Stadler

Subjects
Cancer Research, Oncology
Abstract

Purpose: Over 10% of assessed patients with appendiceal adenocarcinoma (AC) have a pathogenic (P) or likely pathogenic (LP) germline variant, including genes implicated in heritable gastrointestinal cancer syndromes, such as Lynch Syndrome. We defined the clinical and molecular impact of heritable alterations in AC to evaluate the need for dedicated appendiceal screening and prevention strategies in patients with LP/P germline variants. Experimental Design: We performed an integrated germline and somatic molecular analysis for patients with confirmed AC. Patients underwent paired tumor-normal sequencing for up to 90 hereditary cancer-risk genes and 505 genes for somatic mutation profiling. We defined the co-occurrence of LP/P germline variants and second-hit pathogenic somatic alterations. The associations between germline variants and patient clinicopathologic features were also evaluated. Results: Twenty-five out of 237 patients (10.5%) carried pathogenic or likely pathogenic germline variants in cancer susceptibility genes. Clinicopathologic characteristics and AC-specific survival were similar in patients with or without germline variants. Most (92%, N=23/25) patients with germline variants demonstrated no second-hit somatic alterations, including loss of heterozygosity. Two patients with a germline APC I1307K low-penetrance founder variant exhibited secondary somatic pathogenic alterations in APC. However only one patient tumor exhibited APC-mediated WNT-signaling dysregulation; a plausible consequence of multiple somatic APC mutations with no germline variant contribution. Four patients had germline variants in PMS2 or MSH2 associated with Lynch Syndrome, yet their cancers were microsatellite-stable. Conclusions: Germline variants are likely incidental without a contributory driver role in AC. AC screening in patients with germline variants is not clearly merited.

Published
2023

107. Reply to M.C. Strach et al

Author

Michael B. Foote, Garrett M. Nash, and Andrea Cercek

Subjects
Cancer Research, Oncology
Published
2023

112. Practical Considerations in Diagnosing and Managing Early-Onset GI Cancers

Author

Melissa A. Lumish and Andrea Cercek

Subjects
Cancer Research, Oncology, Incidence, Humans, Middle Aged, Gastrointestinal Neoplasms
Abstract

The incidence of early-onset (EO) GI cancers occurring in individuals younger than age 50 years has been rising at an alarming rate over the past two decades. Although this rise in incidence among young patients correlates with increased rates of obesity, changes in diet, and alterations in the environment, the effects of these environmental factors on carcinogenesis, metastasis, and treatment response are unknown. Although several unique clinical trends exist among EO-GI cancers and their average-onset GI cancer counterparts, GI cancers are molecularly indistinct between younger and older patients, and no data support distinct treatment paradigms for patients with EO disease. The majority of EO-GI cancers are not explained by germline changes. There remains a critical need for further research to understand the pathogenesis and optimal management of EO-GI cancers. In addition, current screening strategies are not adequate to identify EO-GI cancers, and early biomarkers are needed. Specialized centers, with a focus on psychosocial aspects of cancer management, can address the unique care needs of patients with EO-GI cancers.

Published
2022

113. Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy

Author

Julio Garcia-Aguilar, Sujata Patil, Marc J. Gollub, Jin K. Kim, Jonathan B. Yuval, Hannah M. Thompson, Floris S. Verheij, Dana M. Omer, Meghan Lee, Richard F. Dunne, Jorge Marcet, Peter Cataldo, Blase Polite, Daniel O. Herzig, David Liska, Samuel Oommen, Charles M. Friel, Charles Ternent, Andrew L. Coveler, Steven Hunt, Anita Gregory, Madhulika G. Varma, Brian L. Bello, Joseph C. Carmichael, John Krauss, Ana Gleisner, Philip B. Paty, Martin R. Weiser, Garrett M. Nash, Emmanouil Pappou, José G. Guillem, Larissa Temple, Iris H. Wei, Maria Widmar, Sabrina Lin, Neil H. Segal, Andrea Cercek, Rona Yaeger, J. Joshua Smith, Karyn A. Goodman, Abraham J. Wu, and Leonard B. Saltz

Subjects
Cancer Research, Rectal Neoplasms, Chemoradiotherapy, Organ Preservation, Adenocarcinoma, Disease-Free Survival, Neoadjuvant Therapy, Oxaliplatin, Oncology, Antineoplastic Combined Chemotherapy Protocols, Humans, Fluorouracil, Prospective Studies, Capecitabine, Neoplasm Staging
Abstract

PURPOSE Prospective data on the efficacy of a watch-and-wait strategy to achieve organ preservation in patients with locally advanced rectal cancer treated with total neoadjuvant therapy are limited. METHODS In this prospective, randomized phase II trial, we assessed the outcomes of 324 patients with stage II or III rectal adenocarcinoma treated with induction chemotherapy followed by chemoradiotherapy (INCT-CRT) or chemoradiotherapy followed by consolidation chemotherapy (CRT-CNCT) and either total mesorectal excision (TME) or watch-and-wait on the basis of tumor response. Patients in both groups received 4 months of infusional fluorouracil-leucovorin-oxaliplatin or capecitabine-oxaliplatin and 5,000 to 5,600 cGy of radiation combined with either continuous infusion fluorouracil or capecitabine during radiotherapy. The trial was designed as two stand-alone studies with disease-free survival (DFS) as the primary end point for both groups, with a comparison to a null hypothesis on the basis of historical data. The secondary end point was TME-free survival. RESULTS Median follow-up was 3 years. Three-year DFS was 76% (95% CI, 69 to 84) for the INCT-CRT group and 76% (95% CI, 69 to 83) for the CRT-CNCT group, in line with the 3-year DFS rate (75%) observed historically. Three-year TME-free survival was 41% (95% CI, 33 to 50) in the INCT-CRT group and 53% (95% CI, 45 to 62) in the CRT-CNCT group. No differences were found between groups in local recurrence-free survival, distant metastasis-free survival, or overall survival. Patients who underwent TME after restaging and patients who underwent TME after regrowth had similar DFS rates. CONCLUSION Organ preservation is achievable in half of the patients with rectal cancer treated with total neoadjuvant therapy, without an apparent detriment in survival, compared with historical controls treated with chemoradiotherapy, TME, and postoperative chemotherapy.

Published
2022

115. Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer

Author

Walid K. Chatila, Jin K. Kim, Henry Walch, Michael R. Marco, Chin-Tung Chen, Fan Wu, Dana M. Omer, Danny N. Khalil, Karuna Ganesh, Xuan Qu, Anisha Luthra, Seo-Hyun Choi, Yu-Jui Ho, Ritika Kundra, Katharine I. Groves, Oliver S. Chow, Andrea Cercek, Martin R. Weiser, Maria Widmar, Iris H. Wei, Emmanouil P. Pappou, Garrett M. Nash, Philip B. Paty, Qian Shi, Efsevia Vakiani, S. Duygu Selcuklu, Mark T. A. Donoghue, David B. Solit, Michael F. Berger, Jinru Shia, Raphael Pelossof, Paul B. Romesser, Rona Yaeger, J. Joshua Smith, Nikolaus Schultz, Francisco Sanchez-Vega, and Julio Garcia-Aguilar

Subjects
Treatment Outcome, Rectal Neoplasms, Humans, Chemoradiotherapy, Genomics, General Medicine, Neoplasm Recurrence, Local, Transcriptome, Neoadjuvant Therapy, Article, General Biochemistry, Genetics and Molecular Biology, Neoplasm Staging, Retrospective Studies
Abstract

The incidence of rectal cancer is increasing in patients younger than 50 years. Locally advanced rectal cancer is still treated with neoadjuvant radiation, chemotherapy and surgery, but recent evidence suggests that patients with a complete response can avoid surgery permanently. To define correlates of response to neoadjuvant therapy, we analyzed genomic and transcriptomic profiles of 738 untreated rectal cancers. APC mutations were less frequent in the lower than in the middle and upper rectum, which could explain the more aggressive behavior of distal tumors. No somatic alterations had significant associations with response to neoadjuvant therapy in a treatment-agnostic manner, but KRAS mutations were associated with faster relapse in patients treated with neoadjuvant chemoradiation followed by consolidative chemotherapy. Overexpression of IGF2 and L1CAM was associated with decreased response to neoadjuvant therapy. RNA-sequencing estimates of immune infiltration identified a subset of microsatellite-stable immune hot tumors with increased response and prolonged disease-free survival.

Published
2022

116. Sex as a Determinant of Responses to a Coronary Artery Disease Self-Antigen Identified by Immune-Peptidomics

Author

Wai Man Lio, Bojan Cercek, Juliana Yano, Wei Yang, Jonathan Ghermezi, Xiaoning Zhao, Jianchang Zhou, Bo Zhou, Michael R. Freeman, Kuang-Yuh Chyu, Prediman K. Shah, and Paul C. Dimayuga

Subjects
coronary artery disease, atherosclerosis, immune-peptidome, self-antigen, sexual dimorphism, Immunologic diseases. Allergy, RC581-607
Abstract

A significant body of work implicates the adaptive immune response in atherosclerosis, the main underlying cause of coronary artery disease (CAD), yet specific antigens involved remain to be fully identified. The pathobiology of CAD is influenced by sex with many factors that may be involved in the underlying mechanisms. Given the reported sexual dimorphic nature of immune-inflammatory responses, we investigated the influence of sex on potential CAD self-antigens from acute coronary syndrome (ACS) patients using immune-precipitation of soluble HLA Class-I/peptide complexes and mass spectrometry. Relevance of identified self-antigens to atherosclerosis, the major underlying cause of CAD, was tested in the apoE–/– atherosclerotic mouse model. Soluble HLA Class-I complexes from ACS patients and self-reported controls were immune-precipitated and subjected to elution, denaturation and size-exclusion to obtain HLA-bound peptides. Peptides were then subjected to mass spectrometry and patient-unique self-peptides were grouped as common to both female and male, or unique to either sex. Three peptides common to both female and male patients (COL6A1, CDSN, and SAA2), and 2 peptides each unique to female (COL1A1 and COL5A2) or male (SAA1 and KRT 9) patients were selected and mouse homologs of the peptides were screened for self-reactive immune responses in apoE–/– mice. The screening step revealed potential sex-influenced immune responses which was associated with differential immune profiles. Based on the frequency in patient plasma, COL6A1, COL5A2, and KRT 9 peptides were then tested in immunization studies. Neither COL5A2 nor KRT 9 peptide immunization resulted in significant effects on atherosclerosis compared to controls. On the other hand, female mice immunized with COL6A1 peptide had significantly reduced atherosclerosis whereas male mice had significantly increased atherosclerosis, associated with differential immune profiles. Our study identified potential self-antigens involved in atherosclerosis using the immune peptidome of CAD patients. Altering self-reactive immune responses to COL6A1 in apoE–/– mice resulted in differential effects on atherosclerosis burden with sex as a determinant of outcome.

Published
2020
Full Text
View/download PDF

117. IL-7R blockade reduces post-myocardial infarction-induced atherosclerotic plaque inflammation in ApoE−/- mice

Author

Peter M. Mihailovic, Wai Man Lio, Juliana Yano, Jianchang Zhou, Xiaoning Zhao, Kuang-Yuh Chyu, Prediman K. Shah, Bojan Cercek, and Paul C. Dimayuga

Subjects
Biology (General), QH301-705.5, Biochemistry, QD415-436
Abstract

Modulating inflammation by targeting IL-1β reduces recurrent athero-thrombotic cardiovascular events without lipid lowering. This presents an opportunity to explore other pathways associated with the IL-1β signaling cascade to modulate the inflammatory response post-myocardial infarction (MI). IL-7 is a mediator of the inflammatory pathway involved in monocyte trafficking into atherosclerotic plaques and levels of IL-7 have been shown to be elevated in patients with acute MI. Recurrent athero-thrombotic events are believed to be mediated in part by index MI-induced exacerbation of inflammation in atherosclerotic plaques. The objective of the study was to assess the feasibility of IL-7R blockade to modulate atherosclerotic plaque inflammation following acute MI in ApoE−/- mice. Mice were fed Western diet for 12 weeks and then subjected to coronary occlusion to induce an acute MI. IL-7 expression was determined using qRT-PCR and immuno-staining, and IL-7R was assessed using flow cytometry. Plaque inflammation was evaluated using immunohistochemistry. IL-7R blockade was accomplished with monoclonal antibody to IL-7R. IL-7 mRNA expression was significantly increased in the cardiac tissue of mice subjected to MI but not in controls. IL-7 staining was observed in the coronary artery. Plaque macrophage and lipid content were significantly increased after MI. IL-7R antibody treatment but not control IgG significantly reduced macrophage and lipid content in atherosclerotic plaques. The results show that IL-7R antibody treatment reduces monocyte/macrophage and lipid content in the atherosclerotic plaque following MI suggesting a potential new target to mitigate increased plaque inflammation post-MI. Keywords: IL-7R, Plaque inflammation, Myocardial infarction

Published
2019
Full Text
View/download PDF

118. Incomplete Cytoreductive Surgery for Appendiceal and Colorectal Peritoneal Carcinomatosis: Characteristics and Outcomes of an Overlooked Group

Author

Aguirre, Nicole, primary, Goffredo, Paolo, additional, Mohamed, Mostafa, additional, Cercek, Andrea, additional, Pappou, Emmanouil, additional, Paty, Philip B, additional, Smith, Jesse Joshua, additional, Weiser, Martin R, additional, Garcia-Aguilar, Julio E, additional, and Nash, Garrett M, additional

Published
2023
Full Text
View/download PDF

119. Hepatic disease control in patients with intrahepatic cholangiocarcinoma correlates with overall survival

Author

Soares, Kevin C., primary, Jolissaint, Joshua S., additional, McIntyre, Sarah M., additional, Seier, Kenneth P., additional, Gönen, Mithat, additional, Sigel, Carlie, additional, Nasar, Naaz, additional, Cercek, Andrea, additional, Harding, James J., additional, Kemeny, Nancy E., additional, Connell, Louise C., additional, Koerkamp, Bas Groot, additional, Balachandran, Vinod P., additional, D'Angelica, Michael I., additional, Drebin, Jeffrey A., additional, Kingham, T. Peter, additional, Wei, Alice C., additional, and Jarnagin, William R., additional

Published
2023
Full Text
View/download PDF

120. Supplementary Data from PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon

Author

Rousseau, Benoit, primary, Bieche, Ivan, primary, Pasmant, Eric, primary, Hamzaoui, Nadim, primary, Leulliot, Nicolas, primary, Michon, Lucas, primary, de Reynies, Aurelien, primary, Attignon, Valerie, primary, Foote, Michael B., primary, Masliah-Planchon, Julien, primary, Svrcek, Magali, primary, Cohen, Romain, primary, Simmet, Victor, primary, Augereau, Paule, primary, Malka, David, primary, Hollebecque, Antoine, primary, Pouessel, Damien, primary, Gomez-Roca, Carlos, primary, Guimbaud, Rosine, primary, Bruyas, Amandine, primary, Guillet, Marielle, primary, Grob, Jean-Jacques, primary, Duluc, Muriel, primary, Cousin, Sophie, primary, de la Fouchardiere, Christelle, primary, Flechon, Aude, primary, Rolland, Frederic, primary, Hiret, Sandrine, primary, Saada-Bouzid, Esma, primary, Bouche, Olivier, primary, Andre, Thierry, primary, Pannier, Diane, primary, El Hajbi, Farid, primary, Oudard, Stephane, primary, Tournigand, Christophe, primary, Soria, Jean-Charles, primary, Champiat, Stephane, primary, Gerber, Drew G., primary, Stephens, Dennis, primary, Lamendola-Essel, Michelle F., primary, Maron, Steven B., primary, Diplas, Bill H., primary, Argiles, Guillem, primary, Krishnan, Asha R., primary, Tabone-Eglinger, Severine, primary, Ferrari, Anthony, primary, Segal, Neil H., primary, Cercek, Andrea, primary, Hoog-Labouret, Natalie, primary, Legrand, Frederic, primary, Simon, Clotilde, primary, Lamrani-Ghaouti, Assia, primary, Diaz, Luis A., primary, Saintigny, Pierre, primary, Chevret, Sylvie, primary, and Marabelle, Aurelien, primary

Published
2023
Full Text
View/download PDF

121. Data from PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon

Author

Rousseau, Benoit, primary, Bieche, Ivan, primary, Pasmant, Eric, primary, Hamzaoui, Nadim, primary, Leulliot, Nicolas, primary, Michon, Lucas, primary, de Reynies, Aurelien, primary, Attignon, Valerie, primary, Foote, Michael B., primary, Masliah-Planchon, Julien, primary, Svrcek, Magali, primary, Cohen, Romain, primary, Simmet, Victor, primary, Augereau, Paule, primary, Malka, David, primary, Hollebecque, Antoine, primary, Pouessel, Damien, primary, Gomez-Roca, Carlos, primary, Guimbaud, Rosine, primary, Bruyas, Amandine, primary, Guillet, Marielle, primary, Grob, Jean-Jacques, primary, Duluc, Muriel, primary, Cousin, Sophie, primary, de la Fouchardiere, Christelle, primary, Flechon, Aude, primary, Rolland, Frederic, primary, Hiret, Sandrine, primary, Saada-Bouzid, Esma, primary, Bouche, Olivier, primary, Andre, Thierry, primary, Pannier, Diane, primary, El Hajbi, Farid, primary, Oudard, Stephane, primary, Tournigand, Christophe, primary, Soria, Jean-Charles, primary, Champiat, Stephane, primary, Gerber, Drew G., primary, Stephens, Dennis, primary, Lamendola-Essel, Michelle F., primary, Maron, Steven B., primary, Diplas, Bill H., primary, Argiles, Guillem, primary, Krishnan, Asha R., primary, Tabone-Eglinger, Severine, primary, Ferrari, Anthony, primary, Segal, Neil H., primary, Cercek, Andrea, primary, Hoog-Labouret, Natalie, primary, Legrand, Frederic, primary, Simon, Clotilde, primary, Lamrani-Ghaouti, Assia, primary, Diaz, Luis A., primary, Saintigny, Pierre, primary, Chevret, Sylvie, primary, and Marabelle, Aurelien, primary

Published
2023
Full Text
View/download PDF

122. Supplementary Figure from PD-1 Blockade in Solid Tumors with Defects in Polymerase Epsilon

Author

Rousseau, Benoit, primary, Bieche, Ivan, primary, Pasmant, Eric, primary, Hamzaoui, Nadim, primary, Leulliot, Nicolas, primary, Michon, Lucas, primary, de Reynies, Aurelien, primary, Attignon, Valerie, primary, Foote, Michael B., primary, Masliah-Planchon, Julien, primary, Svrcek, Magali, primary, Cohen, Romain, primary, Simmet, Victor, primary, Augereau, Paule, primary, Malka, David, primary, Hollebecque, Antoine, primary, Pouessel, Damien, primary, Gomez-Roca, Carlos, primary, Guimbaud, Rosine, primary, Bruyas, Amandine, primary, Guillet, Marielle, primary, Grob, Jean-Jacques, primary, Duluc, Muriel, primary, Cousin, Sophie, primary, de la Fouchardiere, Christelle, primary, Flechon, Aude, primary, Rolland, Frederic, primary, Hiret, Sandrine, primary, Saada-Bouzid, Esma, primary, Bouche, Olivier, primary, Andre, Thierry, primary, Pannier, Diane, primary, El Hajbi, Farid, primary, Oudard, Stephane, primary, Tournigand, Christophe, primary, Soria, Jean-Charles, primary, Champiat, Stephane, primary, Gerber, Drew G., primary, Stephens, Dennis, primary, Lamendola-Essel, Michelle F., primary, Maron, Steven B., primary, Diplas, Bill H., primary, Argiles, Guillem, primary, Krishnan, Asha R., primary, Tabone-Eglinger, Severine, primary, Ferrari, Anthony, primary, Segal, Neil H., primary, Cercek, Andrea, primary, Hoog-Labouret, Natalie, primary, Legrand, Frederic, primary, Simon, Clotilde, primary, Lamrani-Ghaouti, Assia, primary, Diaz, Luis A., primary, Saintigny, Pierre, primary, Chevret, Sylvie, primary, and Marabelle, Aurelien, primary

Published
2023
Full Text
View/download PDF

123. Supplementary Data from Intraperitoneal Pretargeted Radioimmunotherapy for Colorectal Peritoneal Carcinomatosis

Author

Chandler, Christopher S., primary, Bell, Meghan M., primary, Chung, Sebastian K., primary, Veach, Darren R., primary, Fung, Edward K., primary, Punzalan, Blesida, primary, Burnes Vargas, Daniela, primary, Patel, Mitesh, primary, Xu, Hong, primary, Guo, Hong-fen, primary, Santich, Brian H., primary, Zanzonico, Pat B., primary, Monette, Sébastien, primary, Nash, Garrett M., primary, Cercek, Andrea, primary, Jungbluth, Achim, primary, Pandit-Taskar, Neeta, primary, Cheung, Nai Kong V., primary, Larson, Steven M., primary, and Cheal, Sarah M., primary

Published
2023
Full Text
View/download PDF

124. Figure S2 from Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer

Author

Segal, Neil H., primary, Cercek, Andrea, primary, Ku, Geoffrey, primary, Wu, Abraham J., primary, Rimner, Andreas, primary, Khalil, Danny N., primary, Reidy-Lagunes, Diane, primary, Cuaron, John, primary, Yang, T. Jonathan, primary, Weiser, Martin R., primary, Romesser, Paul B., primary, Stadler, Zsofia K., primary, Varghese, Anna M., primary, Ganesh, Karuna, primary, Yaeger, Rona, primary, Connell, Louise C., primary, Faleck, David, primary, Abou-Alfa, Ghassan K., primary, Mcauliffe, Kathleen C., primary, Vaiskauskas, Pamela, primary, Solter, Mark L., primary, Ogle, Martinique, primary, Adamow, Matthew J., primary, Holland, Aliya, primary, Vedantam, Pallavi, primary, Wong, Phillip, primary, Merghoub, Taha, primary, Vakiani, Efsevia, primary, Hollmann, Travis J., primary, Juluru, Krishna, primary, Chou, Joanne F., primary, Capanu, Marinela, primary, Erinjeri, Joseph, primary, Solomon, Stephen, primary, Yamada, Yoshiya, primary, Kemeny, Nancy, primary, Crane, Christopher H., primary, and Saltz, Leonard B., primary

Published
2023
Full Text
View/download PDF

125. Supplementary Table 4 from SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance

Author

Wasserman, Isaac, primary, Lee, Lik Hang, primary, Ogino, Shuji, primary, Marco, Michael R., primary, Wu, Chao, primary, Chen, Xi, primary, Datta, Jashodeep, primary, Sadot, Eran, primary, Szeglin, Bryan, primary, Guillem, Jose G., primary, Paty, Philip B., primary, Weiser, Martin R., primary, Nash, Garrett M., primary, Saltz, Leonard, primary, Barlas, Afsar, primary, Manova-Todorova, Katia, primary, Uppada, Srijaya Prakash Babu, primary, Elghouayel, Arthur E., primary, Ntiamoah, Peter, primary, Glickman, Jonathan N., primary, Hamada, Tsuyoshi, primary, Kosumi, Keisuke, primary, Inamura, Kentaro, primary, Chan, Andrew T., primary, Nishihara, Reiko, primary, Cercek, Andrea, primary, Ganesh, Karuna, primary, Kemeny, Nancy E., primary, Dhawan, Punita, primary, Yaeger, Rona, primary, Sawyers, Charles L., primary, Garcia-Aguilar, Julio, primary, Giannakis, Marios, primary, Shia, Jinru, primary, and Smith, J. Joshua, primary

Published
2023
Full Text
View/download PDF

126. Figure S2 from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection

Author

Jolissaint, Joshua S., primary, Soares, Kevin C., primary, Seier, Kenneth P., primary, Kundra, Ritika, primary, Gönen, Mithat, primary, Shin, Paul J., primary, Boerner, Thomas, primary, Sigel, Carlie, primary, Madupuri, Ramyasree, primary, Vakiani, Efsevia, primary, Cercek, Andrea, primary, Harding, James J., primary, Kemeny, Nancy E., primary, Connell, Louise C., primary, Balachandran, Vinod P., primary, D'Angelica, Michael I., primary, Drebin, Jeffrey A., primary, Kingham, T. Peter, primary, Wei, Alice C., primary, and Jarnagin, William R., primary

Published
2023
Full Text
View/download PDF

127. Supplementary Data from Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer

Author

Datta, Jashodeep, primary, Smith, J. Joshua, primary, Chatila, Walid K., primary, McAuliffe, John C., primary, Kandoth, Cyriac, primary, Vakiani, Efsevia, primary, Frankel, Timothy L., primary, Ganesh, Karuna, primary, Wasserman, Isaac, primary, Lipsyc-Sharf, Marla, primary, Guillem, Jose, primary, Nash, Garrett M., primary, Paty, Philip B., primary, Weiser, Martin R., primary, Saltz, Leonard B., primary, Berger, Michael F., primary, Jarnagin, William R., primary, Balachandran, Vinod, primary, Kingham, T. Peter, primary, Kemeny, Nancy E., primary, Cercek, Andrea, primary, Garcia-Aguilar, Julio, primary, Taylor, Barry S., primary, Viale, Agnes, primary, Yaeger, Rona, primary, Solit, David B., primary, Schultz, Nikolaus, primary, and D'Angelica, Michael I., primary

Published
2023
Full Text
View/download PDF

128. Supplementary Figure 1 from Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

Author

Lowery, Maeve A., primary, Ptashkin, Ryan, primary, Jordan, Emmet, primary, Berger, Michael F., primary, Zehir, Ahmet, primary, Capanu, Marinela, primary, Kemeny, Nancy E., primary, O'Reilly, Eileen M., primary, El-Dika, Imane, primary, Jarnagin, William R., primary, Harding, James J., primary, D'Angelica, Michael I., primary, Cercek, Andrea, primary, Hechtman, Jaclyn F., primary, Solit, David B., primary, Schultz, Nikolaus, primary, Hyman, David M., primary, Klimstra, David S., primary, Saltz, Leonard B., primary, and Abou-Alfa, Ghassan K., primary

Published
2023
Full Text
View/download PDF

129. Supplemental table 1 from Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients

Author

Yaeger, Rona, primary, Cercek, Andrea, primary, O'Reilly, Eileen M., primary, Reidy, Diane L., primary, Kemeny, Nancy, primary, Wolinsky, Tamar, primary, Capanu, Marinela, primary, Gollub, Marc J., primary, Rosen, Neal, primary, Berger, Michael F., primary, Lacouture, Mario E., primary, Vakiani, Efsevia, primary, and Saltz, Leonard B., primary

Published
2023
Full Text
View/download PDF

130. Supplementary Table 2 from SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance

Author

Wasserman, Isaac, primary, Lee, Lik Hang, primary, Ogino, Shuji, primary, Marco, Michael R., primary, Wu, Chao, primary, Chen, Xi, primary, Datta, Jashodeep, primary, Sadot, Eran, primary, Szeglin, Bryan, primary, Guillem, Jose G., primary, Paty, Philip B., primary, Weiser, Martin R., primary, Nash, Garrett M., primary, Saltz, Leonard, primary, Barlas, Afsar, primary, Manova-Todorova, Katia, primary, Uppada, Srijaya Prakash Babu, primary, Elghouayel, Arthur E., primary, Ntiamoah, Peter, primary, Glickman, Jonathan N., primary, Hamada, Tsuyoshi, primary, Kosumi, Keisuke, primary, Inamura, Kentaro, primary, Chan, Andrew T., primary, Nishihara, Reiko, primary, Cercek, Andrea, primary, Ganesh, Karuna, primary, Kemeny, Nancy E., primary, Dhawan, Punita, primary, Yaeger, Rona, primary, Sawyers, Charles L., primary, Garcia-Aguilar, Julio, primary, Giannakis, Marios, primary, Shia, Jinru, primary, and Smith, J. Joshua, primary

Published
2023
Full Text
View/download PDF

131. Table S1 from Phase II Single-arm Study of Durvalumab and Tremelimumab with Concurrent Radiotherapy in Patients with Mismatch Repair–proficient Metastatic Colorectal Cancer

Author

Segal, Neil H., primary, Cercek, Andrea, primary, Ku, Geoffrey, primary, Wu, Abraham J., primary, Rimner, Andreas, primary, Khalil, Danny N., primary, Reidy-Lagunes, Diane, primary, Cuaron, John, primary, Yang, T. Jonathan, primary, Weiser, Martin R., primary, Romesser, Paul B., primary, Stadler, Zsofia K., primary, Varghese, Anna M., primary, Ganesh, Karuna, primary, Yaeger, Rona, primary, Connell, Louise C., primary, Faleck, David, primary, Abou-Alfa, Ghassan K., primary, Mcauliffe, Kathleen C., primary, Vaiskauskas, Pamela, primary, Solter, Mark L., primary, Ogle, Martinique, primary, Adamow, Matthew J., primary, Holland, Aliya, primary, Vedantam, Pallavi, primary, Wong, Phillip, primary, Merghoub, Taha, primary, Vakiani, Efsevia, primary, Hollmann, Travis J., primary, Juluru, Krishna, primary, Chou, Joanne F., primary, Capanu, Marinela, primary, Erinjeri, Joseph, primary, Solomon, Stephen, primary, Yamada, Yoshiya, primary, Kemeny, Nancy, primary, Crane, Christopher H., primary, and Saltz, Leonard B., primary

Published
2023
Full Text
View/download PDF

132. Supplementary Figure Legends from Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its Inhibition

Author

Yaeger, Rona, primary, Yao, Zhan, primary, Hyman, David M., primary, Hechtman, Jaclyn F., primary, Vakiani, Efsevia, primary, Zhao, HuiYong, primary, Su, Wenjing, primary, Wang, Lu, primary, Joelson, Andrew, primary, Cercek, Andrea, primary, Baselga, Jose, primary, de Stanchina, Elisa, primary, Saltz, Leonard, primary, Berger, Michael F., primary, Solit, David B., primary, and Rosen, Neal, primary

Published
2023
Full Text
View/download PDF

133. Data from Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its Inhibition

Author

Yaeger, Rona, primary, Yao, Zhan, primary, Hyman, David M., primary, Hechtman, Jaclyn F., primary, Vakiani, Efsevia, primary, Zhao, HuiYong, primary, Su, Wenjing, primary, Wang, Lu, primary, Joelson, Andrew, primary, Cercek, Andrea, primary, Baselga, Jose, primary, de Stanchina, Elisa, primary, Saltz, Leonard, primary, Berger, Michael F., primary, Solit, David B., primary, and Rosen, Neal, primary

Published
2023
Full Text
View/download PDF

134. Supplementary Data from Intrahepatic Cholangiocarcinoma with Lymph Node Metastasis: Treatment-Related Outcomes and the Role of Tumor Genomics in Patient Selection

Author

Jolissaint, Joshua S., primary, Soares, Kevin C., primary, Seier, Kenneth P., primary, Kundra, Ritika, primary, Gönen, Mithat, primary, Shin, Paul J., primary, Boerner, Thomas, primary, Sigel, Carlie, primary, Madupuri, Ramyasree, primary, Vakiani, Efsevia, primary, Cercek, Andrea, primary, Harding, James J., primary, Kemeny, Nancy E., primary, Connell, Louise C., primary, Balachandran, Vinod P., primary, D'Angelica, Michael I., primary, Drebin, Jeffrey A., primary, Kingham, T. Peter, primary, Wei, Alice C., primary, and Jarnagin, William R., primary

Published
2023
Full Text
View/download PDF

135. Supplementary Figure 3 from SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance

Author

Wasserman, Isaac, primary, Lee, Lik Hang, primary, Ogino, Shuji, primary, Marco, Michael R., primary, Wu, Chao, primary, Chen, Xi, primary, Datta, Jashodeep, primary, Sadot, Eran, primary, Szeglin, Bryan, primary, Guillem, Jose G., primary, Paty, Philip B., primary, Weiser, Martin R., primary, Nash, Garrett M., primary, Saltz, Leonard, primary, Barlas, Afsar, primary, Manova-Todorova, Katia, primary, Uppada, Srijaya Prakash Babu, primary, Elghouayel, Arthur E., primary, Ntiamoah, Peter, primary, Glickman, Jonathan N., primary, Hamada, Tsuyoshi, primary, Kosumi, Keisuke, primary, Inamura, Kentaro, primary, Chan, Andrew T., primary, Nishihara, Reiko, primary, Cercek, Andrea, primary, Ganesh, Karuna, primary, Kemeny, Nancy E., primary, Dhawan, Punita, primary, Yaeger, Rona, primary, Sawyers, Charles L., primary, Garcia-Aguilar, Julio, primary, Giannakis, Marios, primary, Shia, Jinru, primary, and Smith, J. Joshua, primary

Published
2023
Full Text
View/download PDF

136. Supplementary Table 1 from Comprehensive Molecular Profiling of Intrahepatic and Extrahepatic Cholangiocarcinomas: Potential Targets for Intervention

Author

Lowery, Maeve A., primary, Ptashkin, Ryan, primary, Jordan, Emmet, primary, Berger, Michael F., primary, Zehir, Ahmet, primary, Capanu, Marinela, primary, Kemeny, Nancy E., primary, O'Reilly, Eileen M., primary, El-Dika, Imane, primary, Jarnagin, William R., primary, Harding, James J., primary, D'Angelica, Michael I., primary, Cercek, Andrea, primary, Hechtman, Jaclyn F., primary, Solit, David B., primary, Schultz, Nikolaus, primary, Hyman, David M., primary, Klimstra, David S., primary, Saltz, Leonard B., primary, and Abou-Alfa, Ghassan K., primary

Published
2023
Full Text
View/download PDF

137. Supplementary table 2 from Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients

Author

Yaeger, Rona, primary, Cercek, Andrea, primary, O'Reilly, Eileen M., primary, Reidy, Diane L., primary, Kemeny, Nancy, primary, Wolinsky, Tamar, primary, Capanu, Marinela, primary, Gollub, Marc J., primary, Rosen, Neal, primary, Berger, Michael F., primary, Lacouture, Mario E., primary, Vakiani, Efsevia, primary, and Saltz, Leonard B., primary

Published
2023
Full Text
View/download PDF

139. Supplementary Table 1 from SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance

Author

Wasserman, Isaac, primary, Lee, Lik Hang, primary, Ogino, Shuji, primary, Marco, Michael R., primary, Wu, Chao, primary, Chen, Xi, primary, Datta, Jashodeep, primary, Sadot, Eran, primary, Szeglin, Bryan, primary, Guillem, Jose G., primary, Paty, Philip B., primary, Weiser, Martin R., primary, Nash, Garrett M., primary, Saltz, Leonard, primary, Barlas, Afsar, primary, Manova-Todorova, Katia, primary, Uppada, Srijaya Prakash Babu, primary, Elghouayel, Arthur E., primary, Ntiamoah, Peter, primary, Glickman, Jonathan N., primary, Hamada, Tsuyoshi, primary, Kosumi, Keisuke, primary, Inamura, Kentaro, primary, Chan, Andrew T., primary, Nishihara, Reiko, primary, Cercek, Andrea, primary, Ganesh, Karuna, primary, Kemeny, Nancy E., primary, Dhawan, Punita, primary, Yaeger, Rona, primary, Sawyers, Charles L., primary, Garcia-Aguilar, Julio, primary, Giannakis, Marios, primary, Shia, Jinru, primary, and Smith, J. Joshua, primary

Published
2023
Full Text
View/download PDF

140. Supplementary Figure 2 from SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance

Author

Wasserman, Isaac, primary, Lee, Lik Hang, primary, Ogino, Shuji, primary, Marco, Michael R., primary, Wu, Chao, primary, Chen, Xi, primary, Datta, Jashodeep, primary, Sadot, Eran, primary, Szeglin, Bryan, primary, Guillem, Jose G., primary, Paty, Philip B., primary, Weiser, Martin R., primary, Nash, Garrett M., primary, Saltz, Leonard, primary, Barlas, Afsar, primary, Manova-Todorova, Katia, primary, Uppada, Srijaya Prakash Babu, primary, Elghouayel, Arthur E., primary, Ntiamoah, Peter, primary, Glickman, Jonathan N., primary, Hamada, Tsuyoshi, primary, Kosumi, Keisuke, primary, Inamura, Kentaro, primary, Chan, Andrew T., primary, Nishihara, Reiko, primary, Cercek, Andrea, primary, Ganesh, Karuna, primary, Kemeny, Nancy E., primary, Dhawan, Punita, primary, Yaeger, Rona, primary, Sawyers, Charles L., primary, Garcia-Aguilar, Julio, primary, Giannakis, Marios, primary, Shia, Jinru, primary, and Smith, J. Joshua, primary

Published
2023
Full Text
View/download PDF

141. Supplementary Figure 1 from SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance

Author

Wasserman, Isaac, primary, Lee, Lik Hang, primary, Ogino, Shuji, primary, Marco, Michael R., primary, Wu, Chao, primary, Chen, Xi, primary, Datta, Jashodeep, primary, Sadot, Eran, primary, Szeglin, Bryan, primary, Guillem, Jose G., primary, Paty, Philip B., primary, Weiser, Martin R., primary, Nash, Garrett M., primary, Saltz, Leonard, primary, Barlas, Afsar, primary, Manova-Todorova, Katia, primary, Uppada, Srijaya Prakash Babu, primary, Elghouayel, Arthur E., primary, Ntiamoah, Peter, primary, Glickman, Jonathan N., primary, Hamada, Tsuyoshi, primary, Kosumi, Keisuke, primary, Inamura, Kentaro, primary, Chan, Andrew T., primary, Nishihara, Reiko, primary, Cercek, Andrea, primary, Ganesh, Karuna, primary, Kemeny, Nancy E., primary, Dhawan, Punita, primary, Yaeger, Rona, primary, Sawyers, Charles L., primary, Garcia-Aguilar, Julio, primary, Giannakis, Marios, primary, Shia, Jinru, primary, and Smith, J. Joshua, primary

Published
2023
Full Text
View/download PDF

142. Supplementary Figure Legends from SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance

Author

Wasserman, Isaac, primary, Lee, Lik Hang, primary, Ogino, Shuji, primary, Marco, Michael R., primary, Wu, Chao, primary, Chen, Xi, primary, Datta, Jashodeep, primary, Sadot, Eran, primary, Szeglin, Bryan, primary, Guillem, Jose G., primary, Paty, Philip B., primary, Weiser, Martin R., primary, Nash, Garrett M., primary, Saltz, Leonard, primary, Barlas, Afsar, primary, Manova-Todorova, Katia, primary, Uppada, Srijaya Prakash Babu, primary, Elghouayel, Arthur E., primary, Ntiamoah, Peter, primary, Glickman, Jonathan N., primary, Hamada, Tsuyoshi, primary, Kosumi, Keisuke, primary, Inamura, Kentaro, primary, Chan, Andrew T., primary, Nishihara, Reiko, primary, Cercek, Andrea, primary, Ganesh, Karuna, primary, Kemeny, Nancy E., primary, Dhawan, Punita, primary, Yaeger, Rona, primary, Sawyers, Charles L., primary, Garcia-Aguilar, Julio, primary, Giannakis, Marios, primary, Shia, Jinru, primary, and Smith, J. Joshua, primary

Published
2023
Full Text
View/download PDF

143. Data from Pilot Trial of Combined BRAF and EGFR Inhibition in BRAF-Mutant Metastatic Colorectal Cancer Patients

Author

Yaeger, Rona, primary, Cercek, Andrea, primary, O'Reilly, Eileen M., primary, Reidy, Diane L., primary, Kemeny, Nancy, primary, Wolinsky, Tamar, primary, Capanu, Marinela, primary, Gollub, Marc J., primary, Rosen, Neal, primary, Berger, Michael F., primary, Lacouture, Mario E., primary, Vakiani, Efsevia, primary, and Saltz, Leonard B., primary

Published
2023
Full Text
View/download PDF

145. Supplementary Table S1 from Coaltered Ras/B-raf and TP53 Is Associated with Extremes of Survivorship and Distinct Patterns of Metastasis in Patients with Metastatic Colorectal Cancer

Author

Datta, Jashodeep, primary, Smith, J. Joshua, primary, Chatila, Walid K., primary, McAuliffe, John C., primary, Kandoth, Cyriac, primary, Vakiani, Efsevia, primary, Frankel, Timothy L., primary, Ganesh, Karuna, primary, Wasserman, Isaac, primary, Lipsyc-Sharf, Marla, primary, Guillem, Jose, primary, Nash, Garrett M., primary, Paty, Philip B., primary, Weiser, Martin R., primary, Saltz, Leonard B., primary, Berger, Michael F., primary, Jarnagin, William R., primary, Balachandran, Vinod, primary, Kingham, T. Peter, primary, Kemeny, Nancy E., primary, Cercek, Andrea, primary, Garcia-Aguilar, Julio, primary, Taylor, Barry S., primary, Viale, Agnes, primary, Yaeger, Rona, primary, Solit, David B., primary, Schultz, Nikolaus, primary, and D'Angelica, Michael I., primary

Published
2023
Full Text
View/download PDF

146. Supplementary figures from Mechanisms of Acquired Resistance to BRAF V600E Inhibition in Colon Cancers Converge on RAF Dimerization and Are Sensitive to Its Inhibition

Author

Yaeger, Rona, primary, Yao, Zhan, primary, Hyman, David M., primary, Hechtman, Jaclyn F., primary, Vakiani, Efsevia, primary, Zhao, HuiYong, primary, Su, Wenjing, primary, Wang, Lu, primary, Joelson, Andrew, primary, Cercek, Andrea, primary, Baselga, Jose, primary, de Stanchina, Elisa, primary, Saltz, Leonard, primary, Berger, Michael F., primary, Solit, David B., primary, and Rosen, Neal, primary

Published
2023
Full Text
View/download PDF

147. Supplementary Table 3 from SMAD4 Loss in Colorectal Cancer Patients Correlates with Recurrence, Loss of Immune Infiltrate, and Chemoresistance

Author

Wasserman, Isaac, primary, Lee, Lik Hang, primary, Ogino, Shuji, primary, Marco, Michael R., primary, Wu, Chao, primary, Chen, Xi, primary, Datta, Jashodeep, primary, Sadot, Eran, primary, Szeglin, Bryan, primary, Guillem, Jose G., primary, Paty, Philip B., primary, Weiser, Martin R., primary, Nash, Garrett M., primary, Saltz, Leonard, primary, Barlas, Afsar, primary, Manova-Todorova, Katia, primary, Uppada, Srijaya Prakash Babu, primary, Elghouayel, Arthur E., primary, Ntiamoah, Peter, primary, Glickman, Jonathan N., primary, Hamada, Tsuyoshi, primary, Kosumi, Keisuke, primary, Inamura, Kentaro, primary, Chan, Andrew T., primary, Nishihara, Reiko, primary, Cercek, Andrea, primary, Ganesh, Karuna, primary, Kemeny, Nancy E., primary, Dhawan, Punita, primary, Yaeger, Rona, primary, Sawyers, Charles L., primary, Garcia-Aguilar, Julio, primary, Giannakis, Marios, primary, Shia, Jinru, primary, and Smith, J. Joshua, primary

Published
2023
Full Text
View/download PDF

149. Clinical Outcomes Associated With Pembrolizumab Monotherapy Among Adults With Diffuse Malignant Peritoneal Mesothelioma

Author

Marmarelis, Melina E., primary, Wang, Xiao, additional, Roshkovan, Leonid, additional, Grady, Connor B., additional, Miura, John T., additional, Ginsberg, Michelle S., additional, Ciunci, Christine A., additional, Egger, Jacklynn, additional, Walker, Suzanne, additional, Cercek, Andrea, additional, Foote, Michael B., additional, Litzky, Leslie A., additional, Nash, Garrett, additional, Haas, Andrew R., additional, Karakousis, Giorgos C., additional, Cengel, Keith A., additional, Katz, Sharyn I., additional, Zauderer, Marjorie G., additional, Langer, Corey J., additional, and Offin, Michael, additional

Published
2023
Full Text
View/download PDF

150. Molecular Classification of Appendiceal Adenocarcinoma

Author

Foote, Michael B., primary, Walch, Henry, additional, Chatila, Walid, additional, Vakiani, Efsevia, additional, Chandler, Chris, additional, Steinruecke, Felix, additional, Nash, Garrett M., additional, Stadler, Zsofia, additional, Chung, Sebastian, additional, Yaeger, Rona, additional, Braghrioli, Maria Ignez, additional, Shia, Jinru, additional, Kemel, Yelena, additional, Maio, Anna, additional, Sheehan, Margaret, additional, Rousseau, Benoit, additional, Argilés, Guillem, additional, Berger, Michael, additional, Solit, David, additional, Schultz, Nikolaus, additional, Diaz, Luis A., additional, and Cercek, Andrea, additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results